DUBLIN, May 1, 2023 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra™ AV2 ...
Medtronic plc MDT recently announced favorable data from its study on MARVEL 2 (Micra Atrial Tracking Using A Ventricular accELerometer). The study results demonstrate that an investigational set of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Long-term real-world data showed favorable performance ...
DUBLIN, Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra™ AV2 and Micra™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results